Updated Date: Thu, 11 Jun 2020 00:00:00 EDT
Category: Uncategorized
Ultragenyx’s Crysvita scores FDA nod in 2nd ultra-rare bone disorder kblankenship Thu, 06/18/2020 – 14:03
A High Court Judge has declared that doctors who face misconduct charges at medical practitioners tribunals should not […]
The UK has launched its subscription style payment model for antibiotics, with the first two drugs to be […]
Scientists develop AI-based tool to predict adverse drug events. Such events are responsible for some 2 million U.S. […]
One of the largest problems with cancer treatment is the development of resistance to anticancer therapies. A research […]
Emergent plots $75M expansion to produce viral vectors for expanding gene therapy business kblankenship Thu, 06/18/2020 – 09:04
Roche’s Actemra falls short in Italian study in early-stage COVID-19 pneumonia esagonowsky Thu, 06/18/2020 – 09:12
Legacy nabs Missouri plant to amp up logistics and packaging work fkansteiner Thu, 06/18/2020 – 09:23
